The use of corticosteroids, a group of anti-inflammatory drugs, along with antibiotics, significantly reduces treatment failure among patients with severe community-acquired pneumonia from 31% to 13 %, at the same time that improves their prognosis. The Journal of the American Medical Association (JAMA) publishes this study led by researchers from Hospital Clínic of Barcelona, IDIBAPS and the Networked Biomedical Research Center for Respiratory Diseases (CIBERES). Dr. Antoni Torres, Pneumologist at Hospital Clínic of Barcelona, professor at the University of Barcelona and coordinator of the IDIBAPS and CIBERES group that has led this research, is the first author of the paper.
Viernes, 04 de junio de 2021
Award for the best Abstract
SOCAP in the celebration of its XXXVIII “Diada Pneumológica” has awarded the Award for the best Abstract to our researchers for their participation in the CIBERESUCICOVID project in the research of Covid-19.
Miércoles, 25 de febrero de 2015
The use of anti-inflammatory drugs significantly reduces treatment failure in severe pneumonia
Article published in JAMA on Feb 17 2015
Lunes, 26 de enero de 2015
Dr. Laia Fernández Barat wins SEPAR-ERS Joint fellowship